Barclays Maintains Overweight on Elanco Animal Health, Lowers Price Target to $21
Elanco Animal Health +0.81% Pre
Elanco Animal Health ELAN | 12.51 12.51 | +0.81% 0.00% Pre |
Barclays analyst Balaji Prasad maintains Elanco Animal Health (NYSE:
ELAN) with a Overweight and lowers the price target from $23 to $21.